Jun Lu

Title: Jun Lu: Innovator in Angiogenesis Inhibition

Introduction

Jun Lu is a notable inventor based in Monmouth Junction, NJ (US). He has made significant contributions to the field of medical research, particularly in the area of angiogenesis inhibition. His work focuses on developing innovative methods to treat and prevent disorders associated with angiogenesis.

Latest Patents

Jun Lu holds a patent for "Chirally pure isomers of itraconazole for use as angiogenesis inhibitors." This patent describes methods of inhibiting angiogenesis and outlines the administration of anti-angiogenesis compounds to a subject. His innovative approach aims to provide effective treatments for various disorders linked to abnormal blood vessel growth.

Career Highlights

Jun Lu is affiliated with Johns Hopkins University, where he continues to advance his research in the field of angiogenesis. His work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

Jun Lu collaborates with esteemed colleagues, including Jing Xu and Wie Shi. Their combined expertise contributes to the ongoing research and development of effective anti-angiogenesis strategies.

Conclusion

Jun Lu's contributions to the field of angiogenesis inhibition highlight his innovative spirit and dedication to medical research. His patent and ongoing work at Johns Hopkins University position him as a key figure in the pursuit of effective treatments for angiogenesis-related disorders.